Page 2 - Phillip Sharp News Today

The two high-profile barristers for each side in the Roberts-Smith case have given the court starkly different takes on the evidence as they make their final pitches

The two high-profile barristers for each side in the Roberts-Smith case have given the court starkly different takes on the evidence as they make their final pitches

When the Covid-19 pandemic laid bare discrepancies in resource equity, MIT postdoc Dig Bijay Mahat worked to help Nepal navigate widespread Covid testing requirements and vaccine rollouts.

Melissa J. Moore ’84, Candice Malone Long M.B.A. ’96 and Colleen Gorman ’95 have played an integral part in making their companies’ COVID-19 vaccines available to the public.

MIT Startup Exchange, a program within MIT Corporate Relations, has became the largest university-based platform for startups to connect with corporations.

NEW YORK — Shares of Biogen surged on Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.Biogen, which is known for its Alzheimer's drug Aduhelm and a neurology-focused medication pipeline, approached Samsung on a potential deal that could be valued at more than $42 billion, according to a

NEW YORK — Shares of Biogen surged on Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.Biogen, which is known for its Alzheimer's drug Aduhelm and a neurology-focused medication pipeline, approached Samsung on a potential deal that could be valued at more than $42 billion, according to a

Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company

NEW YORK, Dec 30 — Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than US$40 billion (RM167.3 billion). Biogen, which is known for its Alzheimer’s drug Aduhelm and a neurology-focused medication...

NEW YORK - Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.